GSA CAPITAL PARTNERS LLP - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 94 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$394,000
-29.6%
262,544
-33.4%
0.02%
-38.2%
Q4 2017$560,000
-47.9%
394,044
-15.9%
0.03%
-53.4%
Q3 2017$1,074,000
+46.9%
468,795
-13.5%
0.07%
+52.1%
Q2 2017$731,000
+18.9%
541,795
+88.5%
0.05%
+45.5%
Q1 2017$615,000
-18.9%
287,395
+67.1%
0.03%
-26.7%
Q4 2016$758,000
-41.5%
171,995
-35.6%
0.04%
-35.7%
Q3 2016$1,296,000
+324.9%
267,195
+189.2%
0.07%
+311.8%
Q2 2016$305,000
+45.2%
92,395
+55.8%
0.02%
+30.8%
Q1 2016$210,00059,2950.01%
Other shareholders

There were no reported owners of ARALEZ PHARMACEUTICALS INC in Q2 2016.

NameSharesValueWeighting ↓
View complete list of ARALEZ PHARMACEUTICALS INC shareholders